Calix Ltd (ASX: CXL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Calix Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $851.21 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 160.61 million
Earnings per share -0.042
Dividend per share N/A
Year To Date Return 392.09%
Earnings Yield N/A
Franking 60%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Calix Ltd (ASX: CXL)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
30 Jun 2004 $0.0500 60.00% 09 Jul 2004

CXL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Calix Ltd

Calix Ltd Australian technology company. It has developed a patent-protected, platform technology that produces new materials and processes, targeted at solving global challenges in water and wastewater treatment, sustainable food production, CO2 mitigation, and advanced battery development. Its core technology platform includes the Calix Flash Calciner (CFC). It has operations in Australia, New Zealand, Asia, Europe, and the United States of America.

CXL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
22 Oct 2021 $5.30 $0.01 0.19% 209,990 $5.29 $5.44 $5.23
21 Oct 2021 $5.29 $-0.01 -0.19% 211,072 $5.27 $5.30 $5.13
20 Oct 2021 $5.30 $0.04 0.76% 201,050 $5.40 $5.56 $5.27
19 Oct 2021 $5.26 $0.01 0.19% 212,630 $5.25 $5.31 $5.11
18 Oct 2021 $5.25 $-0.10 -1.87% 212,205 $5.40 $5.45 $5.25
15 Oct 2021 $5.35 $-0.13 -2.37% 289,376 $5.55 $5.61 $5.30
14 Oct 2021 $5.48 $0.18 3.40% 271,955 $5.30 $5.51 $5.16
13 Oct 2021 $5.30 $-0.22 -3.99% 469,244 $5.50 $5.50 $5.25
12 Oct 2021 $5.52 $-0.03 -0.54% 280,672 $5.57 $5.58 $5.37
11 Oct 2021 $5.55 $-0.30 -5.13% 762,204 $5.90 $5.90 $5.36
08 Oct 2021 $5.85 $0.38 6.95% 1,357,816 $5.47 $5.90 $5.21
07 Oct 2021 $5.47 $0.69 14.44% 741,668 $4.95 $5.48 $4.90
06 Oct 2021 $4.78 $0.03 0.63% 465,164 $4.75 $5.04 $4.75
05 Oct 2021 $4.75 $-0.07 -1.45% 518,152 $4.62 $4.84 $4.54
04 Oct 2021 $4.82 $-0.18 -3.60% 790,523 $5.00 $5.19 $4.54
01 Oct 2021 $5.00 $-0.22 -4.21% 481,384 $5.25 $5.25 $4.93
30 Sep 2021 $5.22 $0.11 2.15% 326,845 $5.11 $5.33 $5.10
29 Sep 2021 $5.11 $-0.18 -3.40% 330,473 $5.13 $5.19 $5.00
28 Sep 2021 $5.29 $0.09 1.73% 396,774 $5.30 $5.45 $5.17
27 Sep 2021 $5.20 $0.24 4.84% 491,480 $4.96 $5.35 $4.96
24 Sep 2021 $4.96 $-0.21 -4.06% 366,384 $5.20 $5.21 $4.96

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
11 Oct 2021 Philip (Phil) Hodgson Buy 204 $1,133,437
Conversion of securities.
11 Oct 2021 Philip (Phil) Hodgson Exercise 204 $1,133,437
Conversion of securities. 1,035,160 - Performance Rights
06 Oct 2021 Helen Fisher Buy 2 $9,850
On-market trade.
29 Sep 2021 Helen Fisher Buy 3 $17,539
On-market trade.
13 Apr 2021 Mark Sceats Buy 4 $9,558
Participation in share purchase plan. As per announcement on 16/04/2021.
13 Apr 2021 John (Jack) Hamilton Buy 11 $23,894
Participation in share purchase plan.
13 Apr 2021 John (Jack) Hamilton Buy 2 $4,778
Participation in share purchase plan.
13 Apr 2021 Philip (Phil) Hodgson Transfer 1 $2,545,927
Off-market transfer. Assuming 1,106,925 Indirect shares transferred to Direct shares.
13 Apr 2021 Philip (Phil) Hodgson Buy 4 $9,558
Participation in share purchase plan.
13 Apr 2021 Philip (Phil) Hodgson Transfer 1 $2,545,927
Off-market transfer. Assuming 1,106,925 Indirect shares transferred to Direct shares.
13 Apr 2021 Peter Turnbull Buy 4 $9,558
Participation in share purchase plan.
19 Mar 2021 Helen Fisher Buy 3 $7,941
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Peter John Turnbull Non-Executive ChairmanNon-Executive Director Feb 2009
Mr Turnbull is an experienced chair and professional non-executive director of publicly listed, unlisted and evolving technology companies. His sector experience includes oil and gas, mining, technology commerialisation and industrial manufacturing. Peter has over 25 years of senior executive and corporate legal experience with some of Au including Newcrest Mining, BTR Nylex and Energex. Peter also has corporate regulatory and government policy experience through working with the Australian Securities & Investments Commission and the Hong Kong Securities & Futures Commission. Peter is a member of the ASIC Corporate Governance Consultative Panel and is speaker and writer on global governance issues. He is Member of Risk Management Committee.
Ms Helen E Fisher Non-Executive Director Sep 2020
Ms Fisher is financial experience and knowledge and global networks in the Life Sciences sector. Helen is CEO and Managing Director of Bio Capital Impact Fund (BCIF) and a director of BARD1 Life Sciences Ltd, a cancer diagnostics company. Helen is also the Chair of the Victorian branch of AusBiotech. Prior to establishing the BCIF, Helen was a partner of Deloitte and led Deloitte's life sciences practice in Australia for 5 years, having had many years' experience in the life sciences and health care sector. She also focuses in the financial services sector, servicing some of the banks and funds and has been involved in setting up a number of international funds, as well as advised on a number of M&A transactions. Helen has provided strategic tax advice to publicly listed and multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore structures, IP and supply chain management. Helen will also Chair Calix's Risk Committee.
Mr Lance Adrian Wingate O'Neill Non-Executive Director Feb 2014
Mr O'Neill is a Director of DFB (Australia) Pty Ltd and has worked in institutional equity, fixed income sales/trading and corporate finance in international securities and investment markets for over thirty years in Australia, UK and USA. He is the chair of MediaZest Plc and EP&F Capital Plc and in addition is and has been a director of, and investor in, a number of private and public companies in Australia, UK, and the USA.
Dr Mark Geoffrey Sceats Chief ScientistExecutive Director Feb 2014
Mr Sceats has 40 years of experience and has previously worked at the James Franck Institute at the University of Chicago, and as an Assistant Professor of the University of Rochester NY, USA, where he was awarded the Alfred P Sloan Fellowship for his work. Later he was employed by the University of Sydney as a Reader in the School of Chemistry for his research work on chemical reaction kinetics. Mark has published more than 140 academic papers in physical chemistry and is an inventor of 36 patented inventions. He is Member of Technology Committee.
Dr John (Jack) Andrew Hamilton Non-Executive Director Nov 2012
Dr Hamilton has over 30 years of experience both locally and internationally in operations management covering refining, petrochemicals and gas production, marketing, strategy and liquefied natural gas project management. Jack was previously CEO of Exergen Pty Ltd and formerly, director of NWS Ventures with Woodside Energy. He has held non-executive director roles including Renu Energy Limited and DUET Group Ltd. He is Chairman of Technology Committee and Risk Management Committee.
Dr Philip (Phil) Hargraves Hodgson Chief Executive OfficerManaging Director Feb 2014
Mr Hodgson has career with Shell, where for over 14 years he developed experience across all sectors of the downstream oil industry including refining and supply, marketing and sales, pricing strategy, risk management, corporate strategy, and mergers and acquisitions. From 2007 to 2013, he ran his own consultancy providing project development, commercial, M&A, and management experience to sectors including LNG, biofuel, clean coal, geothermal energy, building products, logistics and fast-moving consumer goods. He is Member of Technology Committee.
Mr Darren Charles Chief Financial OfficerCompany Secretary
-
Darren Charles Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 28,599,377 19.34%
J P Morgan Nominees Australia Pty Limited 9,399,081 6.36%
National Nominees Limited 8,638,122 5.84%
Mr Paul Crowther 8,500,000 5.75%
Nicholas Merriman 8,113,286 5.49%
BNP Paribas Noms Pty Ltd <Drp> 7,649,554 5.17%
Citicorp Nominees Pty Limited 7,029,923 4.75%
Ubs Nominees Pty Ltd 4,845,566 3.28%
Dr Mark Geoffrey Sceats 4,277,246 2.89%
Mark Geoffrey Sceats <Sceats Superannuation Fund> 3,172,236 2.15%
Pigeons Super Pty Limited <The Hodgson Family S/F Nc> 2,188,280 1.48%
Jacob S Ulrich 2,083,133 1.41%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp Nc> 1,629,295 1.10%
Jeneil Super Pty Ltd <Jeneil Super Fund Nc> 1,554,532 1.05%
Adam Vincent 1,528,601 1.03%
Brian N C Sweeney 1,490,001 1.01%
Oliver Gillie & Susan Gillie 1,280,455 0.87%
Mr John Andrew Hamilton 1,221,250 0.83%
Phil Hodgson 1,106,925 0.75%
Shareholder Services Pty Ltd 1,098,091 0.74%

Profile

since

Note